Hosted on MSN1d
Biomerica’s tests for IBD conditions gain CE-marking under EU’s IVDR
The IVDR certification allows the company to pursue market expansion within Europe's in vitro diagnostic market.
Biomerica achieves IVDR certification in European union
Biomerica (BMRA) announces that its food intolerance products for Crohn’s Disease and Ulcerative Colitis have achieved CE-marking under the ...
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis
Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union ...
360dx2d
Biomerica Nabs IVDR Certification for Food Intolerance Tests
The tests identify specific foods that may trigger inflammation in patients with Crohn's disease and ulcerative colitis.
CNN1y
Biomerica, Inc.
Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions.
Nasdaq9d
Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal
IRVINE, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global leader in advanced medical diagnostic solutions, is proud to announce that patients with Irritable Bowel ...
Nasdaq9d
Biomerica's inFoods IBS Offers Personalized Dietary Solutions to Alleviate Symptoms of Irritable Bowel Syndrome
Biomerica primarily focuses on gastrointestinal and inflammatory diseases where the Company has multiple diagnostic and therapeutic products in development. The Private Securities Litigation ...
February 2025's Top US Penny Stocks To Consider
As the S&P 500 reaches new heights and the Nasdaq Composite hovers near record levels, investors are closely watching market dynamics that continue to evolve amid mixed trading signals. In this ...